Innovative Blue Horizon Stem Cell Therapies benefit NYC-based Real Estate Investor

April 21, 2014 - PRLog -- Gerard Rem, MBA Harvard graduate and NYC-based real estate investor, learned about the extraordinary benefits of the Blue Horizon International stem cell treatment from a friend who had traveled to China on business and had this breakthrough treatment during his stay there.

Mr. Rem, a lifelong resident of Manhattan, had become more familiar with the tremendous benefits of stem cell treatment after his consultation with stem-cell guru, Dr Brian Mehling, and he then made the decision to travel to China immediately, to experience the innovative treatment for himself.

Mr Rem underwent the painless, 45 minute-long procedure under the close supervision of Dr Doncheng Wu, a Professor at Wuhan University School of Basic Medical Science, Chu Tian Scholar, and Director of the Stem Cell Centre, Hongqiao Brain Hospital in Wuhan, China and Dr Brian Mehling, MD, the founder of Blue Horizon International and Blue Horizon Stem Cells.

Upon his return to New York, Mr Rem stated, " I received more benefits from the stem cell treatments than I ever imagined I would. The procedure went smoothly and was comfortable. Not only did the stem cells help repair my arthritic shoulder but they also gave me an increased energy level. "
He also added, "At all stages of the treatment and the trip, we were escorted by very informative and helpful medical professionals. The stem cell treatments have helped me in ways that traditional medicine is not capable of doing. "

Highly regarded orthopedic trauma surgeon and stem-cell guru, Brian Mehling, MD is the founder of the American-based company, Blue Horizon International, which includes Blue Horizon Stem Cells, Blue Horizon Skin Care, and its charitable division Blue Horizon Charitable Foundation (BHCF). As founder, Dr. Mehling has overseen a newly opened treatment and research facility in Bratislava, Slovakia. He has also managed the premiere of a clinic in China where more than 2,600 stem cell treatment procedures on over 600 patients have been successfully performed. By strategically placing the new clinic in Slovakia the most innovative stem cell treatments for orthopedic joint injuries are now available for the global market.

“Stem cell treatments are, without a doubt, the future of medicine,” stated Dr. Mehling.  “It is important that people learn about the possibilities stem cell research offers and how to receive this beneficial treatment on charity basis, through our Blue Horizon Charitable Foundation."

BHCF is the charity arm of Blue Horizon International and is dedicated to promoting and enhancing the quality of medical care given to children and adults across the globe.  To achieve this goal, BHCF donates stem cell treatments to eligible individuals.  For more information, visit www.bluehorizonfoundation.org.